MAPKAPK5 and breast cancer: On the other hand, the mTORC1 inhibitor rapamycin, similar to the PRAK inhibitor, imposed a suppressive effect on the invasion of B16 cells (Supplementary Fig. 5b) as well as the lung metastasis of ER+ breast cancer cell MCF7 (Supplementary Fig. 5c).